Catalase and paraoxonase in hypertensive type 2 diabetes mellitus: Correlation with glycemic control

Clinical Biochemistry

Volumn 32, Issue 6, 1999, Pages 423-427

  Sözmen, Bulent ^a   Delen, Yasemin ^b   Girgin, Ferhan K ^b   Sözmen, Eser Yildirim ^b  

^a Ataturk State Hospital   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Catalase; Hypertension; Paraoxonase; Superoxide dismutase; Type 2 diabetes mellitus

Indexed keywords

ARYLDIALKYLPHOSPHATASE; CATALASE; HEMOGLOBIN A1C; LIPID PEROXIDE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL;

AGED; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; CATALASE; CHOLESTEROL; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; ESTERASES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REFERENCE VALUES; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 0344613971     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(99)00034-X     Document Type: Article

References (21)

1. Sundaram R.K., Bhaskar A., Vijayalingham S., Viswanathan M., Mohan R., Shanmugasundaram K.R. Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci. 90:1996;255-260.
2. Wohaieb S.A., Godin D.V. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Diabetes. 36:1987;1014-1018.
3. Baynes J.W. Role of oxidative stress in development of complications in diabetes. Diabetes. 40:1991;405-412.
4. Maxwell S.R.J., Thomason H., Sandler D., et al. Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann Clin Biochem. 34:1997;638-644.
5. Dzau V.J. Atherosclerosis and hypertension; mechanisms and interrelationships. J Cardiovasc Pharmacol. 15:(suppl 5):1990;S59-S64.
6. Ferriss J.B. The causes of raised blood pressure in insulin-dependent and non-insulin dependent diabetes. J Hum Hypertens. 5:1991;245-254.
7. Sözmen B., Kazaz C., Taşiran D., Tüzün S., Sözmen E.Y. Effect of N-dicyclopropylmethyl-amino-2-oxazoline (S-3341) on antioxidant status and nitric oxide in hypertensive patients. Curr Med Res Opin. 14:1998;89-97.
8. Nakazono K., Watanabe N., Matsuno K., Sasaki J., Sato T., Inoue M. Does superoxide underlie in the pathogenesis of hypertension? Proc Natl Acad Sci USA. 88:1991;10045-10048.
9. Mackness M.I., Mackness B., Durrington P.N., Connelly P.W., Hegele R.A. Paraoxonase; biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol. 7:1996;69-75.
10. Mackness M.I., Harty D., Bhatnagar D., et al. Serum paraoxonase activity in familial hypercholesterolemia and insulin-dependent diabetes mellitus. Atherosclerosis. 86:1991;193-199.
11. Ruiz J., Blanche H., James R.W., et al. Gln-Arg 192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. Lancet. 346:1995;869-872.
12. Goth J. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 196:1991;143-152.
13. Sun Y., Larry W., Oberley W., Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem. 34:1988;497-500.
14. Eckerson H.W., Wyte C., La Du B.N. The human serum paraoxonase/arylsterase polymorphism. Am J Hum Genet. 35:1983;1126-1138.
15. Taylor R., Agius L. The biochemistry of diabetes. Biochem J. 250:1988;625-640.
16. Freeman B.A., Crapo J.D. Biology of disease free radicals and tissue injury . Lab Invest. 47:1982;412-425.
17. Arai K., Iizuka S., Tada Y., Oikawa K., Taniguchi N. Increase in the glycosylated form of erythrocyte Cu-Zn superoxide dismutase in diabetes and close associaton of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta. 924:1987;292-296.
18. Laplaud R.M., Dantoine T., Chapman M.J. Paraoxonase as a risk marker for cardiovascular disease facts and hypotheses . Clin Chem Lab Med. 36:1998;431-441.
19. Antikainen M., Murtomaki S., Syvanne M., et al. The Gln-Arg 191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest. 98:1996;883-885.
20. Suehiro T., Nakauchi Y., Yamamoto M., et al. Paraoxonase gene polymorphism in Japanese subjects with coronary artery disease. Int J Cardiol. 57:1996;69-73.
21. Hegele R.A., Connelly P.W., Scherer S.W., et al. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 82:1997;3373-3377.